Baird analyst Brian Skorney said he is Incrementally bullish on Curis (NASDAQ: CRIS) following 4Q14 earnings. The firm maintained ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE